美股市场个股详情
ANIP ANI Pharmaceuticals
- 59.390
- +1.530+2.64%
收盘价 11/27 16:00 (美东)
- 58.870
- -0.520-0.88%
盘前 08:20 (美东)
12.48亿总市值-126361市盈率TTM
59.560最高价57.500最低价22.87万股成交量57.790今开57.860昨收1344.90万成交额1.43%换手率69.87市盈率(静)2101.78万总股本70.81052周最高3.07市净率9.53亿流通值48.20052周最低--股息TTM1605.24万流通股392.040历史最高--股息率TTM3.56%振幅4.800历史最低58.806平均价1股每手
关于ANI Pharmaceuticals公司
ANI Pharmaceuticals Inc 开发、制造和销售仿制药。 它生产液体、粉末和口服固体剂量产品。 其产品开发领域包括麻醉剂、溶瘤剂、激素和类固醇，以及涉及缓释和组合产品的复杂配方。 它的一些通用产品包括红霉素琥珀酸乙酯、甲基睾酮酯化雌激素 (EEMT)、依托度酸非诺贝特、氟伏沙明、氢化可的松灌肠剂和万古霉素。 它的地理部门是美国和加拿大，其中大部分收入来自美国。
公司介绍
公司代码ANIP
公司名称ANI Pharmaceuticals
上市日期2003/10/01
成立日期1996
CEOMr. Nikhil Lalwani
所属市场纳斯达克
员工数量642
年结日12-31
公司地址210 Main Street West
城市Baudette
省份明尼苏达州
国家美国
邮编56623
电话1-218-634-3500
董事高管
- 姓名
- 职务
- 年薪
- Nikhil Lalwani
- Director, President and Chief Executive Officer
- 807.84万
- Krista Davis
- Senior Vice President and Chief Human Resources Officer
- --
- Stephen P. Carey
- Senior Vice President, Finance, Principal Accounting Officer and Chief Financial Officer
- 257.61万
- Christopher Mutz
- Senior Vice President and Head of Rare Diseases
- 191.45万
- Chad Gassert
- Senior Vice President, Corporate Development and Strategy
- 189.62万
- Thomas Rowland
- Senior Vice President, Corporate Development & Strategy
- --
- Ori Gutwerg
- Senior Vice President, Generics
- 194.17万
- Meredith W. Cook
- Senior Vice President, General Counsel and Corporate Secretary
- --
- James G. Marken
- Senior Vice President, Operations and Product Development
- --
- Patrick D. Walsh
- Chairman of the Board
- 42.22万
- Muthusamy Shanmugam
- Director, Head of Research and Development and Chief Operating Office, Novitium Operations
- --
- Matthew J. Leonard
- Director
- 92.83万
- Antonio R. Pera
- Independent Director
- 39.33万
- Thomas J. Haughey
- Independent Director
- 41.22万
- Jeanne Thomas
- Independent Director
- 39.58万
- Dr. Renee P. Tannenbaum, D.Pharm.
- Independent Director
- 39.24万
分析
目标价预测
暂无数据
热议
美股
综合热度
股票代码
最新价
涨跌幅
暂无数据